Overview

A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants

Status:
COMPLETED

Trial end date:
2024-08-15

Target enrollment:

Participant gender:

Summary

This study aims to assess any impact of VH4524184 on the pharmacokinetic (PK) profile of an ethinyl estradiol (EE) and norethindrone acetate (NEA) containing oral contraceptive (OC) administered to healthy adult female participants.

Phase:

PHASE1

Details

Lead Sponsor:

ViiV Healthcare

Treatments:

norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination